Latest posts by Lancet Global Health (see all)
- [Articles] Measuring Iran’s success in achieving Millennium Development Goal 4: a systematic… - Mar. 29, 2017
- [Comment] Achieving equity in maternal health in China: more to be done - Mar. 25, 2017
- [Articles] Progress and challenges in maternal health in western China: a Countdown to 2015… - Mar. 22, 2017
- [Corrections] Correction to 2016; 5: e392–93 - Mar. 17, 2017
These neonatal herpes estimates mark the first attempt to quantify the global burden of this rare but serious condition. Better collection of primary data for neonatal herpes is crucially needed to reduce uncertainty and refine future estimates. These data are particularly important in resource-poor settings where we may have underestimated cases. Nevertheless, these first estimates suggest development of new HSV prevention measures such as vaccines could have additional benefits beyond reducing genital ulcer disease and HSV-associated HIV transmission, through prevention of neonatal herpes.